EP2046323 - Bibliographic data

COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

Last update 15/07/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

SPECTRUM PHARMACEUTICALS, INC.

157 Technology Drive
Irvine, CA 92618
États-Unis d'Amérique

THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS

352 Henry Administration Building 506 South Wright Street
Urbana Illinois 61801
États-Unis d'Amérique
(72) Inventors

GULATI, Anil

1929 Lisson Road
Naperville, IL 60665
États-Unis d'Amérique

REDDY, Guru

120 Arden
Irvine, CA 92620
États-Unis d'Amérique

LENAZ, Luigi

11 Planetree Court
Newton, PA 18940
États-Unis d'Amérique
(74) Agent

Mail recipient

GREEN, MARK CHARLES

Urquhart-Dykes & Lord LLP 3rd Floor 33 Glasshouse Street
London W1B 5DG
Royaume-Uni

(21) Request number EP07799742.7
(22) Request date 20/07/2007

(11) Publication number EP2046323
Publication date 13/02/2013

(54) Title of the invention COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS
(51) International classification A61K 31/337A61K 31/513A61K 31/704A61K 38/03A61K 38/10A61K 38/16A61K 38/20A61K 45/06A61P 35/00A61K 31/282A61K 31/4745A61K 31/519A61K 31/7072A61P 13/08
International classification (before reform) None

Claimed priority

(31) Number: 461961
(32) Date: 02/08/2006
(33) Country: US

Initial application None
Divisional application None

Expected annuity Annuity: 7 - Amount: 90 € - Due date 31/07/2013
Surtax: 7 - Amount: 18 € - Due date 03/02/2014
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2013/1, of 31/03/2013

History

Publication de la délivrance du brevet européen - Legal date 13/02/2013


Entrée en période de grâce du brevet d'invention - Legal date 31/07/2013


Déchéance du brevet d'invention après période de grâce - Legal date 31/07/2013